Recent Articles

‘ExacTrac’ Tumor Motion Monitoring : Enhanced Respiration-Triggered Radiotherapy
‘ExacTrac’ Tumor Motion Monitoring : Enhanced Respiration-Triggered Radiotherapy
ExacTrac Infrared Monitoring device is the exciting new innovation by BrainLAB which is an adjunct tool to existent therapy machines to monitor patient positions during radiation therapy sessions. CBCT (Cone Beam CT) is the commonly employed device in several cancer care facilities for patient set-up; but is incapable of tracking the patient’s positioning alterations which could take place at the time of radiotherapy. The ExacTrac Infrared Monitoring device could be mounted on the ceiling and helps in tracking a patient’s positions all through therapy delivery thus offering doctors greater self-confidence for targeted radiation therapy. An infinitesimal budge from the preliminary patient set-up could have a damaging effect on healthy tissues adjoining the tumor. The ExacTrac technology  [...]

August 1st, 2010 | News, Tumor
LITT Nanoparticle Technology – New Cancer Treatment Shows Promise
LITT Nanoparticle Technology – New Cancer Treatment Shows Promise
A group of investigators at the Wake Forest Univ. Baptist Medical Center lately made an announcement that they have made noteworthy improvement in an investigational cancer treatment called LITT (laser-induced thermal therapy). The LITT treatment involves introduction of nanoparticles to the region surrounding the tumor after which laser treatment is employed for heating these nanoparticles and destroying the cancer-ridden tissues. Study investigators from Wake Forest fine-tuned the therapy by employing iron-comprising MWCNTs (multi-walled carbon nanotubes – strands of hollow carbon which are ten thousand fold finer in comparison to a hair in humans) that could be traced inside the body of a patient via the usage of Magnetic resonance imaging (MRI), thus facilitating improved precision delivery  [...]

July 26th, 2010 | News
IMAT Treatment – Beneficial Technology for Paediatric Brain Cancer
IMAT Treatment – Beneficial Technology for Paediatric Brain Cancer
A research presentation put forth during the fifty-second yearly conference of AAPM (Association of Physicists in Medicine) shows that kids with brain cancer undergoing radiation therapy (X-ray beams focused for killing malignant cells and shrivelling tumors) might be benefited by a technology termed as ‘IMAT’ or intensity modulated arc therapy. Intensity modulated arc therapy method is reliant on novel attributes of the newest generation of X-ray treatment device which provide X ray sources in continually rotating varied directions encircling the patient at the time of therapy. This technique helps to increase directions from which the X-ray beams are coming from. The research that was carried out by physical scientists from the St. Jude Children’s Hospital located in Memphis Tennessee  [...]

July 21st, 2010 | Brain Cancer, News
Nun’s Syndrome and Breast Cancer Epidemic
Nun’s Syndrome and Breast Cancer Epidemic
Annual sky-rocketing breast cancer cases continue to be a matter of grave concern in spite of periodical declarations of promising novel drugs and therapies. Just ten years back, a female’s lifetime risk of getting breast cancer was 1in twelve, however currently it has become 1 in 9. Particularly bothersome are Britain’s statistics wherein breast cancer constitutes one-third of female’s cancers and afflicted over forty-seven thousand females during 2007. Even though wide-ranging breast cancer causes exist, but it has become apparent that current lifestyles that women has adopted is accountable. The most hyped exemplar is Kylie Minogue being identified with breast cancer in thirty-six. New-fangled studies in the United States have shown that breast tumors are arising (6 years sooner) among  [...]

July 19th, 2010 | Breast Cancer, News
Novel Treatments and Medications for Aggressive, Slow-Spreading Lymphomas
Novel Treatments and Medications for Aggressive, Slow-Spreading Lymphomas
For several decades, non-Hodgkin’s lymphoma (NHL) research has remained in a neutral state. Conventionally conducted chemotherapy was capable of beating the slow-spreading lymphoma types and keeping several patients in a state of remission. However, on every instant lymphomas recurred, they learnt abler means of surviving such lethal medications. However, there have been noteworthy advancements of novel medications in the last decade. Antibody Therapy In the nineties, sanguinity was restored when scientists comprehended the manner in which to mass manufacture antibodies to combat a type of immune B-cell, known as monoclonal antibodies observed in ninety percent of the NHL cases. These monoclonal antibodies obliterated lymphoma cells by exploiting the capability of the immune system. The Manner  [...]

July 14th, 2010 | Non-Hodgkins Lymphoma
Latest Advancements in Non-Hodgkin Lymphoma Research
Latest Advancements in Non-Hodgkin Lymphoma Research
Studies conducted for probing the reasons, preclusion and therapy of NHL or non-Hodgkin lymphoma are on-going in several medical facilities across the globe. Genetics Researchers continue to make notable advancements in comprehending the genetics of non-Hodgkin lymphoma. They are gaining knowledge about the manner in which genes alter for causing uninhibited cell growth, lengthier existence and not maturing. This would thus assist them in creating medicines for blocking this process. New-fangled tests for finding and classifying lymphoma are additionally being researched. Several of such tests could be capable of forecasting the manner in which the cancer would show response to chemotherapy, how totally the cancer could be obliterated by therapy or if there is a likelihood of the cancer coming  [...]

July 12th, 2010 | Non-Hodgkins Lymphoma
Understanding Symptoms of Non-Hodgkins Lymphoma
Understanding Symptoms of Non-Hodgkins Lymphoma
Non-Hodgkins Lymphoma (or NHL or lymphoma) is a cancer starting in the lymphocytes cells (lymph nodes, lymphoid tissue like bone marrow, spleen) that are part of the body’s immune system. Lymphomas would originate in the lymphoid tissue and could then metastasize to the other body organs. Non-Hodgkin lymphoma and Hodgkin lymphoma (other terms – Hodgkin’s disease or Hodgkin’s lymphoma) are duo key forms of lymphomas. The cellular appearances of such duo lymphoma forms differ microscopically. However in several scenarios, specialized laboratory tests might become necessary for differentiating them. Inception and Metastasis of non-Hodgkins lymphoma Non-Hodgkin lymphoma or NHL is mostly segregated on the basis of microscopic appearance of cancerous cells, particular characteristics of the  [...]

July 7th, 2010 | Non-Hodgkins Lymphoma
Abortion Procedure linked to three-fold augmented Breast Cancer Risk
Abortion Procedure linked to three-fold augmented Breast Cancer Risk
An abortion procedure could treble a female’s chances of imminently getting breast cancer, according to study investigators. A group of researchers have claimed this startling outcome following an in-depth study that probes how mothers who breastfeed are shielded from developing breast cancer. As the study team drew to a conclusion that nursing provides noteworthy shielding from cancer, they additionally cited that the peak cited risk aspects in getting breast cancer was termination of pregnancy or the abortion procedure. Other breast cancer risk factors include the inception of menopause and those women who smoke. The study outcomes printed in the journal ‘Cancer Epidemiology’, are the most up-to-date trial that finds an association in-between breast cancer and the abortion procedure. The  [...]

June 30th, 2010 | Breast Cancer, News
New-Fangled Drug Combo Effectual Against Pancreas Cancer – Broccoli Emerges as Cancer Combater
New-Fangled Drug Combo Effectual Against Pancreas Cancer – Broccoli Emerges as Cancer Combater
The novel cancer drug sorafenib shows potential. Sorafenib is employed for treatment of later staging cancers of kidney and liver and is additionally effective in pancreas cancer by tackling tumor stem cells. A research group headed by Prof. Ingrid Herr, HOD, Molecular Oncosurgery, Heidelberg Univ. Hospital in collaboration with the German Cancer Research Center, evaluated the novel substance in rodent and pancreatic cancer cells. It hampered resistance-exhibiting cancer stem cells and was additionally effectual when merged with sulforaphene, an organic constituent present in broccoli. Annually, pancreatic cancer develops in around 12900 Germans and is often spotted quite later on thus leading to fewer individuals surviving the analysis more than a year’s time. Particularly, early harbinger  [...]

June 28th, 2010 | News, Pancreatic Cancer
Risk of Brain Tumor Development Five-Fold Among Mobile Phone Users
Risk of Brain Tumor Development Five-Fold Among Mobile Phone Users
Mobile phone users have a fivefold greater likelihood of developing brain tumors as compared to people using land lines, researchers have cautioned. Researchers have stated that several earlier studies probing cell phone safety considerably undervalued the risk of cancer developing and that brain tumor formation is commonly found on that side of a person’s head where the cell phone had been held against as compared to the other side. Following re-analysis of previous researches, the study authors reached a conclusion that risk of developing such tumors would lay in-between ten to five hundred percent more with protracted cell phone usage. Helming the study, Lloyd Morgan cautioned that the study outcomes elevated the likelihood of a brain tumor epidemic until individuals alter their patterns  [...]

June 23rd, 2010 | News, Tumor